Literature DB >> 17310000

A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans.

Georges Maire1, Sylvie Fraitag, Louise Galmiche, Frédérique Keslair, Nathalie Ebran, Marie-José Terrier-Lacombe, Yves de Prost, Florence Pedeutour.   

Abstract

BACKGROUND: The diagnosis of dermatofibrosarcoma protuberans (DFSP) in childhood is often difficult because of the deceptive appearance of the lesions. Little is known about congenital DFSP, the frequency of which is probably underestimated because the initial lesion may pass unnoticed. OBSERVATIONS: We studied 9 DFSP congenital cases (8 plaques and 1 nodule) initially suspected to be benign lesions. The first biopsies or excisions were performed after a delay of 5(1/2) months to 15 years. All cases were CD34+. Histologic patterns were similar to the DFSP adult classic pattern in 4 cases. One case was a Bednar tumor. The histologic diagnosis of the 4 remaining cases was difficult. The collagen, type I, alpha 1-platelet-derived growth factor beta fusion gene (COL1A1-PDGFB) was detected by means of reverse transcriptase-polymerase chain reaction or fluorescence in situ hybridization.
CONCLUSIONS: All cases of congenital DFSP were difficult to identify clinically. The diagnosis was suspected by means of histologic and immunohistochemical evaluation and was confirmed using molecular analyses. This study illustrates the difficulties and pitfalls of the recognition of congenital DFSP and emphasizes the value of immunohistochemical study with anti-CD34 and complementary molecular analysis for all cutaneous spindle cell tumors and plaques in neonates and infants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17310000     DOI: 10.1001/archderm.143.2.203

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

1.  Medallion-like dermal dendrocyte hamartoma: differential diagnosis with congenital atrophic dermatofibrosarcoma protuberans.

Authors:  Minseok Cheon; Kyung Eun Jung; Hei Sung Kim; Jun Young Lee; Hyung-Ok Kim; Chan Kum Park; Young Min Park
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

2.  Status report on the management of dermatofibrosarcoma protuberans: is there a viable role for the use of imatinib mesylate? In which cases may it be therapeutically helpful and in which cases not?

Authors:  Grace K Kim
Journal:  J Clin Aesthet Dermatol       Date:  2011-03

Review 3.  Malignant Superficial Mesenchymal Tumors in Children.

Authors:  Philippe Drabent; Sylvie Fraitag
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

4.  Dermatofibrosarcoma protuberans in a 10-year-old child.

Authors:  Uwe Wollina
Journal:  J Dermatol Case Rep       Date:  2013-12-30

Review 5.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

6.  Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion.

Authors:  Laurence Bianchini; Georges Maire; Bernard Guillot; Jean-Marie Joujoux; Philippe Follana; Marie-Pierre Simon; Jean-Michel Coindre; Florence Pedeutour
Journal:  Virchows Arch       Date:  2008-02-06       Impact factor: 4.064

7.  Complete remission of a periorbital dermatofibrosarcoma protuberans with adjuvant imatinib mesylate in a child.

Authors:  Hsi Yen; Shin-Chen Pan; Chien-Hun Huang; Tak-Wah Wong
Journal:  JAAD Case Rep       Date:  2015-06-08

8.  Atrophic dermatofibrosarcoma protuberans: report of a case demonstrated by detecting COL1A1-PDGFB rearrangement.

Authors:  Jianjun Qiao; Kayuri U Patel; Dolores López-Terrada; Hong Fang
Journal:  Diagn Pathol       Date:  2012-11-30       Impact factor: 2.644

9.  Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masatoshi Naito
Journal:  Genet Res Int       Date:  2011-07-28

Review 10.  Cutaneous soft tissue sarcomas: survival-related factors.

Authors:  Areti Gkantaifi; Alexandros Diamantis; Davide Mauri; Ioanna Nixon; Anastassios Kyriazoglou; Ioannis Baloyiannis; Nikolaos Tsoukalas; Nikolaos Charalampakis; Dimitrios Schizas; Francesco Cuccia; Filippo Alongi; Ramon Andrade de Mello; George Iliadis; Konstantinos Kamposioras; Michalis Mazonakis; Maria Tolia
Journal:  Arch Dermatol Res       Date:  2021-07-17       Impact factor: 3.033

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.